Auspex Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Auspex Pharmaceuticals (ASPX) Prices 4M Common Follo-On at $56.50/Share
January 23, 2015 7:29 AM ESTAuspex Pharmaceuticals (NASDAQ: ASPX) announced the pricing of its underwritten public offering of 4,000,000 shares of its common stock at a price to the public of $56.50 per share. Auspex is offering 3,000,000 shares of common stock and certain existing stockholders of Auspex are offering 1,000,000... More
Auspex Pharmaceuticals (ASPX) Announces 4M Common Offering
January 21, 2015 4:33 PM ESTAuspex Pharmaceuticals (NASDAQ: ASPX) announced that it has commenced an underwritten public offering of 4,000,000 shares of its common stock. The offering is expected to consist of 3,000,000 shares of common stock to be offered by Auspex and 1,000,000 shares of common stock to be offered by... More
